Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 1
Submit an article Journal homepage
832
Views
12
CrossRef citations to date
0
Altmetric
Oncology

Comparative efficacy of first-line ceritinib and crizotinib in advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer: an adjusted indirect comparison with external controls

Junlong LiAnalysis Group, Inc., Boston, MAUSA; Correspondence[email protected]
,
Stefanie KnollNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Iryna BocharovaAnalysis Group, Inc., Boston, MAUSA;
,
Wenxi TangAnalysis Group, Inc., Boston, MAUSA;
&
James SignorovitchAnalysis Group, Inc., Boston, MAUSA;
Pages 105-111 | Received 11 Sep 2018, Accepted 24 Oct 2018, Published online: 15 Nov 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (12)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.